Adaptimmune Therapeutics plc (ADAP)

NASDAQ: ADAP · Real-Time Price · USD

0.0799

-0.0004 (-0.50%)

At close: Aug 1, 2025, 4:00 PM

0.0790

-0.0009 (-1.13%)

After-hours: Aug 1, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Novel Cell Therapies	60.28M	Log In	Log In	Log In	Log In	Upgrade
Novel Cell Therapies Growth	122.05%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United Kingdom	60.28M	Log In	Log In	Log In	Log In	Upgrade
United Kingdom Growth	122.05%	Log In	Log In	Log In	Log In	Upgrade